![Bernhard Wimmer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernhard Wimmer
Direktor/Vorstandsmitglied bei Evotec (München) GmbH
Ursprung des Netzwerks ersten Grades von Bernhard Wimmer
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Evotec (München) GmbH
![]() Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million.
4
| Subsidiary | Chemicals: Major Diversified | 4 |
BioM AG Munich BioTech Development
![]() BioM AG Munich BioTech Development Investment ManagersFinance BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations.
3
| Subsidiary | Investment Managers | 3 |
BioM Biotech Cluster Development GmbH
![]() BioM Biotech Cluster Development GmbH Medical DistributorsDistribution Services BioM AG is a regional technology transfer and venture capital services company created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition. The firm provides business support services to Munich-based biotechnology companies, focusing on startups. Through BioM Biotech Cluster Development GmbH, established in 2006, BioM coordinates the Munich Biotech Cluster, with the objective of turning it into a leading biotechnology center in Europe. They seek to foster an active cooperation between Bavarian research institutions and corporations. BioM actively invests seed capital in biotechnology startups in the Munich area, and manages a venture capital investment fund invested in high-growth early-stage businesses.
1
| Private Company | Medical Distributors | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bernhard Wimmer
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
![]() IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Investment Managers | Corporate Officer/Principal | |
University of Vienna | College/University | Doctorate Degree | |
NewLab BioQuality AG
![]() NewLab BioQuality AG Medical/Nursing ServicesHealth Services Part of Charles River Laboratories International, Inc., NewLab BioQuality AG is a laboratory services provider that specializes in the analysis of biopharmaceutical drugs. The company is based in Erkrath, Germany. The German company was founded by Jürgen Schumacher. Jürgen Schumacher has been the CEO since incorporation. NewLab BioQuality was acquired by Charles River Laboratories International, Inc. on September 09, 2008 for $52.65 million. | Medical/Nursing Services | Chief Executive Officer | |
University of Regensburg | College/University | Doctorate Degree | |
ApaNovis Biotechnologie GmbH
![]() ApaNovis Biotechnologie GmbH Medical/Nursing ServicesHealth Services ApaNovis Biotechnologie GmbH develops, manufactures, and markets immunotherapeutics for cancer. The company was founded on February 11, 2005 and is headquartered in Munich, Germany. | Medical/Nursing Services | Chief Executive Officer | |
HP Health Solutions Germany GmbH
![]() HP Health Solutions Germany GmbH Miscellaneous Commercial ServicesCommercial Services GNA Biosolutions GmbH develops instruments for molecular pathogen detection. The firm offers PCA technology, lab and portable solutions. The company was founded by Joachim Stehr, Federico Bürsgens and Lars Ullerich in 2010 and is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
MEDIGENE AG | Biotechnology | Founder | |
Genome Research Network | Chief Tech/Sci/R&D Officer | ||
Council of European Bioregions
![]() Council of European Bioregions Miscellaneous Commercial ServicesCommercial Services The Council of European Bioregions is a membership-based biotechnology organization. The Spanish company was founded by Horst Domdey. | Miscellaneous Commercial Services | Founder | |
BIO Deutschland
![]() BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Founder | |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
![]() Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Switch Biotech AG | Founder | ||
Ludwig-Maximilians-Universität München | College/University | Corporate Officer/Principal | |
Baygene | Chief Tech/Sci/R&D Officer | ||
University of Wales (Bangor) | College/University | Masters Business Admin |
Statistik
International
Deutschland | 16 |
Schweden | 2 |
Österreich | 2 |
Spanien | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Commercial Services | 7 |
Consumer Services | 5 |
Health Technology | 3 |
Health Services | 3 |
Finance | 2 |
Operativ
Director/Board Member | 6 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 4 |
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Bernhard Wimmer
- Unternehmensverbindungen